selected scholarly activity
-
chapters
- Hypertension in South Asians. 27-31. 2018
-
conferences
- Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Chest. 642-651. 2021
- Short-Term Changes in Carotid Artery Inflammation Measured by Positron Emission Tomography are Associated With Long Term Atherosclerosis Progression Measured by Magnetic Resonance Imaging. Circulation. 2015
- Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries. Age and Ageing. 629-635. 2014
- Resting heart rate and decline in cognitive function: observations from the ONTARGET/TRANSCEND studies. European Heart Journal. 499-500. 2013
- Contemporary Outcomes of Lung Transplantation Using Extracorporeal Membrane Oxygenation as Bridge. The Journal of Heart and Lung Transplantation. S266-S266. 2013
- EFFECT OF DABIGATRAN ON SERUM APOLIPOPROTEIN B AND APOLIPOPROTEIN A1 CONCENTRATIONS. Journal of the American College of Cardiology. E300-E300. 2013
- Diabetic patients treated with primary angioplasty: Results from a metropolitan area program. Canadian Journal of Cardiology. 55C-55C. 2007
-
journal articles
- Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial.. European Journal of Heart Failure. 2024
- Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial.. Injury. 55:111827. 2024
- Mortality, Cardiovascular Disease, and Their Associations With Risk Factors in Southeast Asia. JACC Asia. 4:624-633. 2024
- Two-way associations between relationship quality and uptake of couples health screening including HIV testing and counselling together: quantitative analysis of a couples cohort in rural South Africa. AIDS Care. 36:187-200. 2024
- Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysis. EClinicalMedicine. 73:102651-102651. 2024
- Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease. JAMA network open. 7:e2421589-e2421589. 2024
- Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry. The Lancet Global Health. 12:e396-e405. 2024
- The impact of bias of underlying literature in guidelines on its recommendations: assessment of the German fluoride guideline. European Archives of Paediatric Dentistry. 25:65-73. 2024
- Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries. European Heart Journal. 44:4435-4444. 2023
- Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in CKD. American Society of Nephrology. Clinical Journal. 18:1408-1415. 2023
- Coordinating Efforts to Reduce the Global Incidence of Cardiovascular Disease. New England Journal of Medicine. 389:1329-1331. 2023
- Global Variations in Heart Failure—Reply. Journal of the American Medical Association (JAMA). 330:1192-1192. 2023
- Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis. Heart. 109:1372-1379. 2023
- The authors reply. Kidney International. 103:1201-1201. 2023
- Global Variations in Heart Failure Etiology, Management, and Outcomes. Journal of the American Medical Association (JAMA). 329:1650-1650. 2023
- Effects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes. JAMA Neurology. 80:251-251. 2023
- Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease. Kidney International. 103:403-410. 2023
- Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial. Nutrition, Metabolism and Cardiovascular Diseases. 33:434-440. 2023
- Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation. PLoS ONE. 18:e0296197-e0296197. 2023
- Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: a randomised controlled trial. The Lancet HIV. 9:e848-e856. 2022
- The cost implications of a polypill for primary prevention in the TIPS-3 trial. European Heart Journal - Quality of Care and Clinical Outcomes. 8:899-908. 2022
- Accelerated Surgery Versus Standard Care in Hip Fracture (HIP ATTACK-1): A Kidney Substudy of a Randomized Clinical Trial. American Journal of Kidney Diseases. 80:686-689. 2022
- Protocol: evaluation of an optimised couples-focused intervention to increase testing for HIV in rural KwaZulu-Natal, South Africa, the Igugu Lethu (‘Our treasure’) cohort study. BMC International Health and Human Rights. 22:1577. 2022
- Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. European Heart Journal. 43:2831-2840. 2022
- Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy. European Heart Journal. 43:2852-2863. 2022
- Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy. European Heart Journal. 43:2841-2851. 2022
- A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis. European Heart Journal. 43:2034-2036. 2022
- Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials. Cardiovascular Research (CVR). 118:897-903. 2022
- Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol. BMJ Open. 12:e057291-e057291. 2022
- Persistent Exertional Intolerance After COVID-19. Chest. 161:54-63. 2022
- Reply to Grignola and Trujillo. Journal of applied physiology. 132:219-219. 2022
- Optimising a couples-focused intervention to increase couples’ HIV testing and counselling using the person-based approach: a qualitative study in Kwa-Zulu Natal, South Africa. BMJ Open. 11:e047408-e047408. 2021
- Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. The Lancet. 398:1133-1146. 2021
- Sex Differences and the Role of Sex Hormones in Pulmonary Hypertension. Clinics in Chest Medicine. 42:457-465. 2021
- Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants. European Heart Journal. 42:2995-3007. 2021
- Arterial load and right ventricular-vascular coupling in pulmonary hypertension. Journal of applied physiology. 131:424-433. 2021
- Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries. Circulation. 143:2129-2142. 2021
- Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals. Cardiovascular Research (CVR). 117:1523-1531. 2021
- Polypill in Persons without Cardiovascular Disease. New England Journal of Medicine. 384:1673-1677. 2021
- The Evolution in Nomenclature, Diagnosis, and Classification of Pulmonary Hypertension. Clinics in Chest Medicine. 42:1-8. 2021
- Polypill with or without Aspirin in Persons without Cardiovascular Disease. New England Journal of Medicine. 384:216-228. 2021
- Causal ordering among risk factors in the PURE study – Authors' reply. The Lancet. 397:279-279. 2021
- The impact of palliative care on clinical and patient‐centred outcomes in patients with advanced heart failure: a systematic review of randomized controlled trials. European Journal of Heart Failure. 22:2340-2346. 2020
- Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial. The Lancet Global Health. 8:e1305-e1315. 2020
- A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. American Heart Journal. 227:56-63. 2020
- Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 396:97-109. 2020
- Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. Europace. 22:870-877. 2020
- Lottery incentives have short‐term impact on ART initiation among men: results from a randomized pilot study. Journal of the International AIDS Society. 23:e25519. 2020
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 395:795-808. 2020
- Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial. The Lancet. 395:698-708. 2020
- Zwakala Ndoda: a cluster and individually randomized trial aimed at improving testing, linkage, and adherence to treatment for hard-to reach men in KwaZulu-Natal, South Africa. Trials. 20:798. 2019
- Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity. JACC: CardioOncology. 1:1-10. 2019
- From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5). Journal of the American College of Cardiology. 74:683-698. 2019
- The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5). Journal of the American College of Cardiology. 74:672-682. 2019
- Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. The Lancet Global Health. 7:e748-e760. 2019
- The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct. American Heart Journal. 206:72-79. 2018
- Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. The Lancet. 391:2325-2334. 2018
- Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart. 104:581-587. 2018
- Age-Related Differences in Socio-demographic and Behavioral Determinants of HIV Testing and Counseling in HPTN 043/NIMH Project Accept. AIDS and Behavior. 22:569-579. 2018
- Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial. Canadian Journal of Cardiology. 34:38-44. 2018
- Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study. The Lancet Diabetes and Endocrinology. 5:774-787. 2017
- Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet Public Health. 2:e411-e419. 2017
- Reducing the Global Burden of Cardiovascular Disease, Part 1. Circulation Research. 121:677-694. 2017
- Reducing the Global Burden of Cardiovascular Disease, Part 2. Circulation Research. 121:695-710. 2017
- Imaging Asymptomatic Individuals for Coronary Disease ∗. JACC Cardiovascular Imaging. 10:318-320. 2017
- The epidemic of cardiovascular disease in South Asians: Time for action. American Heart Journal. 185:150-153. 2017
- Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression. European Journal of Nuclear Medicine and Molecular Imaging. 44:141-150. 2017
- Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations. Canadian Journal of Cardiology. 32:1440-1446. 2016
- Imaging atherosclerosis with positron emission tomography. European Heart Journal. 37:2974-2980. 2016
- A Digital Health Intervention to Lower Cardiovascular Risk. JAMA cardiology. 1:601-601. 2016
- Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation. International Journal of Cardiovascular Imaging. 32:113-119. 2016
- Dabigatran etexilate and reduction in serum apolipoprotein B. Heart. 102:57-62. 2016
- Effectiveness of Quality Improvement Interventions at Reducing Inappropriate Cardiac Imaging. Circulation. Cardiovascular Quality and Outcomes. 9:7-13. 2016
- Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genetics. 16:50. 2015
- Household Shocks and Coping Strategies in Rural and Peri‐Urban South Africa: Baseline Data from the Size Study in Kwazulu‐Natal, South Africa. Journal of International Development. 27:213-233. 2015
- Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries. Age and Ageing. 43:629-635. 2014
- Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. European Heart Journal. 35:1743-1751. 2014
- Takotsubo cardiomyopathy in the setting of necrotizing myopathy. International Journal of Cardiology. 174:e21-e23. 2014
- Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. European Heart Journal. 35:353-364. 2014
- Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization. Clinical Cardiology. 37:48-56. 2014
- Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials. International Journal of Cardiology. 165:17-24. 2013
- Exploring Gene-Environment Relationships in Cardiovascular Disease. Canadian Journal of Cardiology. 29:37-45. 2013
- Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues. JRSM Cardiovascular Disease. 1:1-13. 2012
- Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease. Current Cardiology Reports. 13:287-295. 2011
- Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. Vascular Medicine. 15:515-516. 2010
- Cardiovascular complications of Salmonella enteritidis infection. Canadian Journal of Cardiology. 26:e323-e325. 2010
- Usefulness of Computed Tomographic Coronary Angiography in Patients With Acute Chest Pain With and Without High-Risk Features. American Journal of Cardiology. 106:463-469. 2010
- Repair of Tuberculous Aneurysm of Distal Aortic Arch. Asian Cardiovascular and Thoracic Annals. 11:346-348. 2003
- Relentless Progression of Venous Obstruction in a Case of Budd-Chiari Syndrome Related to Heterozygous Protein C Deficiency. CardioVascular and Interventional Radiology. 24:427-431. 2001
- Impairment of cerebral function following cardiac and other major surgery. European Journal of Cardio-thoracic Surgery. 3:216-221. 1989